NEW YORK, April 24 – Qiagen has acquired Sawady, a Japanese maker of nucleic acids, in return for $18 million of Qiagen common stock, the companies said Tuesday.

The Sawady group of Tokyo, comprises three companies, Sawady Technology, Omgen, and a majority in Accord company, but operates as a single organization employing 40 people. 

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

What happens to scientific papers when certain journals are no longer published? Some scientists are trying to make sure they don't disappear forever.

A study in Microbiome finds that heavy drinkers have an unhealthy mix of bacteria in their mouths.

Doctors and patients are still trying to figure out what role at-home genetic testing should play in healthcare, Newsweek says.

In Genome Research this week, mismatch repair deficiency in C. elegans, retracing transcriptions start site evolution in the human genome, and more.